This is a complex issue. While I certainly understand the goal of lowering drug costs for Canadians—it's an important issue that needs to be studied—we need to look beyond the cost. We also need to look at the value of these innovative drugs and calculate the potential impact on research. You have to look at the whole picture.
On June 18th, 2021. See this statement in context.